林清華醫師簡介

2025年3月22日應台灣生物精神醫學會邀請於台北張榮發國際會議中心做經顱磁刺激專題演講

醫師介紹

院長：林清華 醫學博士/部定教授

學歷

高雄醫學大學醫學研究所醫學博士

台北總民總醫院精神醫學部研究醫師

加拿大英屬哥倫比亞大學(University of British Columbia)憂鬱症中心研究醫師 (2005)

加拿大多倫多大學(University of Toronto)憂鬱症精神藥理中心研究醫師(2013-2014)

經歷

高雄市立凱旋醫院成人精神科主任

台灣精神醫學會精神科專科醫師甄審小組召集人

台灣生物精神學會暨神經精神藥理學理事 

台灣生物精神醫學會腦神經刺激專家委員會委員

愛心會高雄分會會長

高雄精神健康學苑顧問

高雄醫學大學醫學系兼任部定教授

國立中山大學學士後醫學系合聘部定教授

證書

台灣精神醫學會精神科專科醫師證書

台灣老年精神醫學會老年精神科專科醫師證

商業週刊、良醫健康網票選為失智症良醫 

台灣生物精神醫學會經顱磁刺激(rTMS)專家證書

教育部部定教授證書 (高雄醫學大學醫學系送審)

2017年起以第一作者或通訊作者發表於國際期刊之論文

01. Lin CH, Wang FC, Lin SC, Hung YH, Chen CC. A randomized, double-blind, comparison of the efficacy and safety of low-dose olanzapine plus low-dose trifluoperazine versus full-dose olanzapine in the acute treatment of schizophrenia. Schizophr Res 2017;185:80-87. (SCI)

02. Lin CH*, Yang, WC. The relationship between symptom relief and psychosocial functional improvement during acute electroconvulsive therapy for patients with major depressive disorder. Int J Neuropsychopharmacol 2017;20:538-545. (correspondence) (SCI)

03. Li DJ, Lin CH*, Lu MJ. Early improvement predicts treatment outcomes for patients with acute mania: a naturalistic study in Taiwan. J Clin Psychopharmacol 2017;37: 435–440. (correspondence) (SCI)

04. Huang CJ, Hsieh HM, Chiu HC, Wang PW, Lee MH, Li CY, Lin CH*. Impact of Anxiety Disorders on Mortality for Persons With Diabetes: A National Population-Based Cohort Study. Psychosomatics 2017;58:266–273. (correspondence) (SCI)

05. Yang WC, Lin CH*, Wang FC, Lu MJ. Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine. BMC Psychiatry 2017; 17:309. (correspondence) (SCI)

06. Huang CJ, Hsieh, HM, Chiu HC, Wang PW, Lee MH, Li CY, Lin CH*. Health care utilization and expenditures of patients with diabetes comorbid with depression disorder: A national population-based cohort study. Psychiatry Investig 2017;14:770-778. (correspondence) (SCI)

07. Huang CJ, Hsiehc HM, Tud HP, Jiange HJ, Wang PW, Lin CH*. Major depressive disorder in patients with type 2 diabetes mellitus: Prevalence and clinical characteristics. J Affect Disord 2018;227:141-148. (correspondence) (SCI)

08. Lin CH*, Huang CJ, Chen CC. ECT has greater efficacy than fluoxetine in alleviating the burden of illness for patients with major depressive disorder- A Taiwanese pooled analysis. Int J Neuropsychopharmacol 2018;21:63-72. (correspondence) (SCI)

09. Lin CH*, Lin HS, Lin SC, Kuo CC, Wang FC, Hung YH. Early improvement in PANSS‐30, PANSS‐8 and PANSS‐6 scores predicts response/remission during acute treatment of schizophrenia. Acta Psychiatr Scand 2018;137:98-108. (correspondence) (SCI)

10. Lin CH , Lin, SH, Hung YH, Wang FC, Huang CJ. Early prediction of olanzapine-induced weight gain for schizophrenia patients. Psychiatry Res 2018;263:207-211. (SCI)

11. Li DJ, Lin CH*, Chen FC. Factors affecting time to remission for inpatients with bipolar mania - A naturalistic Taiwanese study. J Affect Disord. 2018;232:73-78. (correspondence) (SCI)

12. Hsieh KY, Su CY, Chiu, CH, Lin CH*. Treatment for a Patient with Rapid Cycling Bipolar Disorder Using Maintenance ECT: A Case Report in Taiwan. Tw J Psychiatry 2018;32:168-170. (correspondence) (SCI)

13. Huang CJ, Hsieh HM, Tu HP, Jiang HJ, Wang PW, Lin CH*. Schizophrenia in type 2 diabetes mellitus: Prevalence and clinical characteristics. Eur Psychiatry 2018;54:102-108. (correspondence) (SCI)

14. Lin HS, Lin CH*. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT. J Affect Disord 2019; 245:91-97. (correspondence) (SCI)

15. Lin CH, Park C, McIntyre RS*. Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy. J Affect Disord 2019; 253:154-161. (SCI)

16. Lin CH, Chen FC, Chan HY*, Hsu CC. Time to rehospitalization in patients with schizophrenia receiving long-acting injectable antipsychotics or oral antipsychotics. Int J Neuropsychopharmacol 2019;22:541-547.

17. Huang YH, Zengc BY, Li DJ, Cheng YS, Chen TY, Liang HY, Yang WC, Lin PY, Chen YW, Tseng PT*, Lin CH*. Significantly lower serum and hair magnesium levels in children with attention deficit hyperactivity disorder than controls: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2019:90:134-141. (correspondence) (SCI) (equal contribution)

18. Lin CH*, Wang FC, Huang YH, Lin SC, Kuo CC. Comparison of polypharmacy using low-dose second-generation antipsychotics plus low-dose first-generation antipsychotics with monotherapy using therapeutic-dose second-generation antipsychotics in schizophrenia-a pooled analysis. CNS Spectr 2019;24:632-633. (correspondence) (SCI)

19. Lin CH, Chou LS, Tang SH, Huang CJ*. Do baseline WAIS-III subtests predict treatment outcomes for depressed inpatients receiving fluoxetine? Psychiatry Res 2019;271:279-285. (SCI)

20. Huang CJ, Lin CH*, Wu, JI, Yang WC. The relationship between depression symptoms and anxiety symptoms during acute ECT for patients with major depressive disorder. Int J Neuropsychopharmacol 2019 22;609-615. (correspondence) (SCI)

21. Lin CH, Chen FC, Chan HY*, Hsu CC. A comparison of long-acting injectable antipsychotics with oral antipsychotics on time to rehospitalization within one year of discharge in elderly patients with schizophrenia. Am J Geriatr Psychiatry 2020;28;23-30. (SCI)

22. Lin CH*, Yang WC, Wu, JI. Factors affecting time to resolution of suicidality for 2 depressed patients receiving electroconvulsive therapy. CNS Spectr 2020;25:434-435. (correspondence) (SCI)

23. Yang WC, Lin CH*, Chen CC. Risk factors of relapse after successful electroconvulsive therapy for Taiwanese patients with major depression. J ECT 2020;36:106–110. (correspondence) (SCI)

24. Lin CH*, Su SF, Chou LS. Factors affecting time to suicidal resolution for depressed inpatients during acute treatment with fluoxetine. J Clin Psychopharmacol 2020;40:422-444. (correspondence)

25. Chiu CH, Yan WC, Lin CH*. Electroconvulsive therapy in treatment-resistant obsessive-compulsive disorder comorbid with major depressive disorder A series of 3 cases. J ECT 2020;36: e34-e35. ((correspondence) (SCI)

26. Lin CH*, Yang WC, Chen CC, Cai WR. Comparison of the efficacy of ECT plus agomelatine to ECT plus placebo in treatment-resistant depression. Acta Psychiatr Scand 2020;142:121-131. (correspondence) (SCI)

27. Lin CH, Chan HY*, Hsu CC, Chen FC. Temporal trends in clozapine use at time of discharge among people with schizophrenia at two public psychiatric hospitals in Taiwan, 2006-2017. Sci Rep 2020;10:17984. (SCI)

28. Lin CH, Chen CC, Huang CJ*. ECT vs. fluoxetine in suicidal resolution for patients with major depressive disorder. J ECT 2020;36: 234–241. (SCI)

29. Huang CJ, Hsieh HM, Tu HP, Jiang HJ, Wang PW, Lin CH*. Generalized anxiety disorder in type 2 diabetes mellitus: prevalence and clinical characteristics. Braz J Psychiatry. 2020;42:621-629. (correspondence) (SCI)

30. Lin CH, Chan HY*, Hsu CC, Chen FC. Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics. J Affect Disord 2021;279: 292-298. (SCI)

31. Sua CY, Hsua WT, Lin CH*. Bilateral pedal edema associated with lurasidone: a case report. Int Clin Psychopharmacol 2021;36:58-59. (SCI)

32. Tsai HJ, Yang WC, Tsai SJ, Lin CH*, Yang YC*. Remission of depression is associated with asymmetric hemispheric variation in EEG complexity before antidepressant treatment. J Affect Disord 2021; 281;872-879. (correspondence) (SCI)

33. Lin CH, Chan HY*, Hsu CC, Chen FC. Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics. Eur Neuropsychopharmacol 2021;43:139-146. (SCI)

34. Wang CJ, Chou LS, Lin CH*. Repetitive transcranial magnetic stimulation‐induced hypomania for an elderly patient with major depressive disorder: a case report. Int J Geriatr Psychiatry 2021;36:1460-1461. (correspondence) (SCI)

35. Tsai TH, Shih YJ, Lin CH*. The Efficacy of Electroconvulsive Therapy in a Patient with Posttraumatic Stress Disorder and Major Depression: A Case Report. Tw J Psychiatry 2021;35:210-211. (correspondence) (TSSCI)

36. Wang XY, Chan HY, Lin CH*. Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia A 17-Year Retrospective Cohort Study. J Clin Psychopharmacol 2022;42: 133-139. (correspondence) (SCI)

37. Lin CH, Chan HY*, Wang FC, Hsu CC. Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics. Ther Adv Psychopharmacol 2022;12: 1-12. (correspondence) (SCI)

38. Lin CH*, Yang WC, Chan MH, Chen CC. The relationship between depression and pain during acute electroconvulsive therapy and follow-up period for patients with treatment-resistant depression. J ECT 2022;38: 192–199. (SCI)

39. Lin CH, Lin HY, Lin TC, Chan HY*, Chen JJ. The relation between second-generation antipsychotics and laxative use in elderly patients with schizophrenia. Psychogeriatrics 2022; 22: 718–727. (SCI)

40. Lin CH, Chan HY, Chen CC, Chou FHC*. Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006–2019. J Affect Disord 2022; 318: 386–392. (SCI)

41. Chen FC, Lin TC, Lin HY, Lin CH*. A comparison of core depressive symptom improvement with anxiety symptom reduction for depressed patients treated with fluoxetine. Tw J Psychiatry 2022;36:97-99. (correspondence) (TSSCI)

42. Lin CH, Chan HY, Lin HY, Chen CC*. Fourteen-year trends in the prescribing patterns of pediatric bipolar patients discharged from two public mental hospitals in Taiwan. Asia‐Pacific Psychiatry 2023;15:e12525. (SCI)

43. Tsai HJ, Yang WC , Tsai SJ , Lin CH*, Yang AC*. Right-side frontal-central cortical hyperactivation before the treatment predicts outcomes of antidepressant and electroconvulsive therapy responsivity in major depressive disorder. J Psychiatr Res 2023:161:377-385. (correspondence) (SCI) (equal contribution)

44. Lin TC, Lin CH*. Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006–202. Int J Neuropsychopharmacol. 2023;26:808-816. (correspondence) (SCI)

45. Lin CH* , Huang CJ , Lin TC, Chan HY *, Jiahn-Jyh Chen JJ. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006–2021. Psychiatry Res 2023;330:115575. (SCI)